• FirefoxInstall the new Firefox »
  •  Dow Up 0.86% Nasdaq Up 0.90%

    Theravance Inc. (THRX)

    -NasdaqGS
    19.22 Up 1.16(6.42%) 4:00PM EST
    |After Hours : 19.22 0.00 (0.00%) 5:07PM EST
    Add to Portfolio
    Prev Close:18.06
    Open:18.46
    Bid:N/A
    Ask:22.20 x 300
    1y Target Est:24.00
    Beta:2.58
    Earnings Date:May 4 - May 8 (Est.)
    Day's Range:18.05 - 19.50
    52wk Range:10.58 - 31.80
    Volume:1,468,648
    Avg Vol (3m):997,333
    Market Cap:2.20B
    P/E (ttm):N/A
    EPS (ttm):-1.50
    Div & Yield:1.00 (5.50%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    THRXUp 6.42%2.20B
    AZNDown 0.25%86.81B
    PFEUp 1.31%213.10B

    Key Statistics

    Forward P/E (1 yr):39.22
    P/S (ttm):244.87
    Ex-Dividend Date:10-Mar-15

    Analysts

    Annual EPS Est (Dec-15) :-0.15
    Quarterly EPS Est (Mar-15) :-0.08
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):0.72

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Theravance, Inc., a royalty management company, is focused on developing respiratory products. It receives royalty revenues RELVAR/BREO ELLIPTA (fluticasone furoate/vilanterol, FF/VI), ANORO ELLIPTA (umeclidinium bromide/vilanterol, UMEC/VI), and ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback